Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Rebecca RotheInstitute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany.ORCID 0000-0002-0615-1112
Therés GolleInstitute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany.ORCID 0009-0005-0343-8301
Basma HachkarInstitute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany.ORCID 0009-0006-7757-9745
Tina HörzDepartment of Pediatric Surgery, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.
Jessica PablikDepartment of Pathology, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.
Luise RuppInstitute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany.
Ina DietscheInstitute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany.
Christian KruppaDepartment of Pediatric Surgery, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.
Guido FitzeDepartment of Pediatric Surgery, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.
Marc SchmitzInstitute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany.
Michael HaaseDepartment of Pediatric Surgery, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.ORCID 0000-0002-5897-0320
Rebekka WehnerInstitute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany.
Funding
European Commission 01KT2304BFederal Ministry of Education and Research 01ZX1913CFederal Ministry of Education and Research 03ZU1111LB
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Tertiary Lymphoid Structures Are Associated with Progression-Free Survival of Peripheral Neuroblastic Tumor Patients. · full record | OpenQuestion